LifeStance Health Group, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
LFST$14.56-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net income (loss) | $60,240 | $(2,005) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 42,503 | 41,319 |
| Non-cash operating lease costs | 32,694 | 31,265 |
| Stock-based compensation | 53,117 | 57,997 |
| Amortization of discount and debt issue costs | 758 | 762 |
| Other, net | 4,356 | 1,440 |
| Change in operating assets and liabilities, net of businesses acquired: | ||
| Patient accounts receivable, net | (24,381) | 10,729 |
| Prepaid expenses and other current assets | 33,546 | (10,410) |
| Accounts payable | (513) | 2,868 |
| Accrued payroll expenses | (14,146) | (3,689) |
| Operating lease liabilities | (34,116) | (35,829) |
| Other accrued expenses | 15,979 | (5,856) |
| Net cash provided by operating activities | $170,037 | $88,591 |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Purchases of property and equipment | (37,415) | (25,214) |
| Acquisitions of businesses, net of cash acquired | (9,590) | — |
| Net cash used in investing activities | $(47,005) | $(25,214) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Payments of long-term debt | (10,875) | (5,438) |
| Taxes related to net share settlement of equity awards | (24,919) | (8,607) |
| Proceeds from the exercise of stock options | 5,368 | — |
| Repurchases of common stock | (122,430) | — |
| Net cash used in financing activities | $(152,856) | $(14,045) |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | (29,824) | 49,332 |
| Cash and cash equivalents - beginning of period | 248,642 | 154,571 |
| CASH AND CASH EQUIVALENTS – END OF PERIOD | $218,818 | $203,903 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||
| Cash paid for interest, net | $12,298 | $13,253 |
| Cash paid for taxes, net of refunds | $1,294 | $1,564 |
| SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES | ||
| Contingent consideration incurred in acquisitions of businesses | $3,983 | $— |
| Acquisition of property and equipment included in liabilities | $4,546 | $4,484 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.